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Introduction
Degenerated intervertebral disc disease (DDD) is thought to be
one of the most prevalent causes for chronic low back pain, that
currently has no identified cause [1, 2]. The traditional view dur-
ing much of the last century was that DDD was primarily due to
physical (over)loading as well as changes associated with the
normal aging process. In recent years, however, a dramatic
advance has been made in our understanding of risk factors such
as age, gender, genetics, environmental, chemical (smoking) and
biomechanical influences for disc degeneration, thus changing
our traditional views [3–6]. These advances allow exploration of
new promising treatment modalities for the treatment of DDD,
including cell-based therapies aiming to regenerate disc tissue
and to restore the biological function of a disc rather than only
alleviate the symptoms.
There are two distinct but interdependent cell populations in
the intervertebral disc: nucleus pulposus (NP) cells in the inner
region [7] having chondrocyte-like properties, and annulus
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fibrous (AF) cells in the outer layer having a more fibrocyte-like
phenotype. During the process of DDD, AF and NP cells react
differently to the tissue degeneration. The NP is more vulnera-
ble to degeneration, and the first pathological changes therefore
start in the NP, with cellular loss and proteoglycan breakdown
leading to diminished water-binding capacity and loss of disc
height [8, 9].
So far, different concepts are under pre-clinical and clinical
evaluation for the regeneration of NP tissue. For instance,
re-implantation of NP cells was evaluated in vitro and in vivo for
halting or retarding the process of DDD [10–13]. However, there
are some potential drawbacks of using NP cells, for example
degeneration of the adjacent discs due to NP cells harvesting and
difficulties in obtaining enough NP cells for transplantation. By
contrast, adult mesenchymal stem cells (MSCs) can overcome
these drawbacks: they can be harvested from many sites, such as
bone marrow, fat, muscle, skin without significant donor site mor-
bidity [14]; MSCs can also be expanded in vitro to sufficient num-
bers for transplantation purposes [15]. 
Adipose tissue-derived mesenchymal stem cells (ASCs) have
been identified as a new stem cell source having multilineage dif-
ferentiation potential [16]. ASCs are particularly promising for
clinical application due to their unique combination of minimally
invasive procurement procedures and high stem cell yields [17,
18]. Together, these aspects allow one-step surgical procedures,
in which ASCs are harvested, either or not triggered towards the
desired differentiation lineage, and re-implanted at the site of
interest within a time span of 2–3 hrs [19]. Although this proce-
dure was described for spinal interbody fusion, we hypothesize
that it might also be applicable for regeneration of degenerated
discs by intradiscal injection of ASCs, particularly in early stages
of disc degeneration. 
It has been shown that tissue microenvironments play a crit-
ical role in guiding the differentiation of stem cells in normal
regenerative processes [20, 21]. The NP is such an environment,
characterized by a low density of NP cells and a highly abundant
extracellular matrix (ECM), which contains a large amount of pro-
teoglycans and predominantly collagen type II fibrils. We hypoth-
esize that due to this high matrix-to-cell ratio, most of the ASCs
will encounter matrix contacts and only indirect contact with NP
cells (via soluble factors). 
In a previous study, we demonstrated that NP cells, when cul-
tured in a micromass configuration, can indeed induce a NP phe-
notype in vitro in micromass ASCs, and that they do so by solu-
ble mediators [22]. The current study aims to more closely mimic
the microenvironment the ASCs will encounter after intradiscal
injection, by providing a true 3D nucleus-like environment
through embedding in a collagen type II hydrogel. To assess car-
tilaginous matrix-mediated effects, differentiation-related gene
expression profiles as well as histochemical and morphological
parameters were compared with those of ASCs embedded in col-
lagen type I gels. The results obtained in this study provide
insight in the relative influence of the components separately
(matrix or NP cells), and their possible interaction on the NP phe-
notype induction in ASCs.
Materials and methods
ASCs and NP cells isolation and culture
The human ethical committee of the Free University medical centre approved
the retrieval of human specimens, and informed consent was obtained. 
ASCs were isolated from subcutaneous adipose tissue that was harvested
from patients undergoing elective surgical procedures, as described previous-
ly [22]. Briefly, adipose tissue was cut into small pieces of about 25–50 mm3,
washed with phosphate-buffered saline (PBS) to remove red blood cells and
digested for 60 min. at 37C with 0.5 U/ml Liberase Blendzyme 3 (Roche
Diagnostics, Almere, The Netherlands) in PBS to dissociate the cells from their
ECM. The digested material was passed over a 100-µm-mesh filter to remove
tissue debris, washed several times with PBS and resuspended in ASC culture
medium (Dulbecco’s modified Eagle’s medium [D-MEM, Gibco, Paisley, UK])
supplemented with 500 g/ml streptomycin sulphate (Sigma, St. Louis, MO,
USA), 600 g/ml penicillin (Sigma), 50 g/ml gentamycin (Gibco), 2.5 g/ml
fungizone (Gibco) and 10% foetal bovine serum (FBS, Hyclone, Logan, UT,
USA)]. Cells were plated in 25-cm2 culture flasks at 37C with 5% CO2 in air in
a humidified incubator, cultured for 24–48 hrs, washed to remove unattached
cells and subsequently re-fed with fresh medium every 3–4 days. Upon reach-
ing 80–90% confluency, ASCs were harvested with 0.25% trypsin and 0.1%
ethylenediaminetetraacetic acid in PBS, replated in 75-cm2 culture flasks
(Greiner Bio-One, Kremsmuenster, Austria), and cultured until reaching conflu-
ency again. All cells used were from passage 3 or earlier.
NP cells were derived from a female scoliosis patient who was 16 years
old, and from NP material obtained during posterior lumbar interbody
fusion surgeries from two patients (one 42-year-old male, one 49-year-old
female). Isolation was performed as described for the ASCs, only the
Liberase digestion time was reduced to 30 min., and DMEM-F12 (Gibco)
was used instead of DMEM when preparing the culture medium NP cells at
passage 1 or 2 were used for our experiments. No apparent differences in
NP cell inductive properties were observed.
Preparation of collagen type I/II hydrogels
Collagen type I/II hydrogels were prepared by mixing six parts of either rat
tail collagen type I (R&D Systems, Minneapolis, MN, USA) or chicken ster-
nal collagen type II (Sigma), one part of 10 DMEM (Gibco), one part of
reconstitution buffer (2.2g NaHCO3 in 100 ml of 0.05 N NaOH and 200 mM
HEPES), and two parts of cell suspension. All components were mixed in
ice and applied in 100-l volumes in wells of a 96-well plate for gel con-
traction analysis, or as 100-l droplets in wells of a 6-well culture plate for
co-culture studies. The collagen gel lattices were allowed to form by plac-
ing the plates in a humidified incubator at 378°C in an atmosphere of 5%
CO2 for 1 hr. Subsequently, gels were carefully submerged in ASC culture
medium. The medium was refreshed every 3 days.
Confocal analysis and measurement 
of gel contraction 
Shape and distribution profile of ASCs in collagen type II gels were
determined by confocal microscopy imaging (TCS SP5 Confocal micro-
scope, Leica microsystems, Wetzlar, Germany) after a culture period of
12 hrs. For this purpose, ASCs were labelled according to the manufacturer’s
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instructions with CellTracker® Green CMFDA (Invitrogen, Carlsbad, CA,
USA) prior to collagen type II gel encapsulation. Three different densi-
ties (0.5  106, 1.5  106 and 5.0  106/ml gel) were tested. 
Gel contraction was assessed for the same gel-cell combinations in 
96-well plates. Contraction was monitored at regular intervals during 
14 days by taking digital photographs of the gels with a Nikon Coolpix digital
camera (Nikon, Melville, NY, USA), and quantitation of the gel diameters.
Indirect co-culture system
Indirect co-culture of ASCs and NP cells was carried out by growing ASCs
in six-well plates and growing NP cells in culture inserts (Becton Dickinson
Labware, NJ, USA) having a 0.4-m pore-size filter, allowing communication
between these two cell types via soluble signals only. Micromass culturing
was applied for NP cells by seeding one droplet of medium (400,000
cells/50 l) on the insert as described previously [22]. Five groups were
studied: (i): ASCs cultured in monolayer as control; (ii): ASCs in collagen
type I gels; (iii): ASCs in collagen type II gels; (iv): ASCs in collagen type I
gels  NP cells and (v): ASCs in collagen type II gels  NP cells. The cell
seeding density of ASCs in the gels was 1.5  106/ml gel. Cell distribution
was monitored at regular intervals during 14 days by taking digital photo-
graphs of the gels with a Nikon Coolpix digital camera (Nikon). After
culture for 4, 14 or 21 days, the gel constructs were harvested and
processed for either real time-PCR analysis or histochemical analysis. 
Real-time PCR analysis
Total RNA was extracted from cultured cells using Trizol (Invitrogen)
according to the manufacturer’s instructions. Seven hundred and fifty
nanograms of total RNA was reverse transcribed in 20 l of reverse tran-
scriptase-polymerase chain reaction (RT-PCR) mix (5U transcriptor
reverse transcriptase [Roche Diagnostics]), 0.08 A260 units random
primers (Roche Diagnostics), 1mM of each of dNTP (Invitrogen), 10U
protector Rase inhibitor (Roche Diagnostics) and 1 transcriptor RT
buffer] at 55C for 30 min., and then at 85C for 5 min. to inactivate the
transcriptase. Chondrogenic gene expression (aggrecan, collagen type X
and collagen type IIA and IIB) were determined by real-time PCR by light
cycler (Roche LC 480).
The striking effect of matrix composition and the presence or absence
of NP cells on the aggregation of ASCs within the gels prompted us to also
determine the expression profiles of particular matrix-interacting integrins.
Because the integrins 11, 21 and 101 were previously shown to
interact with collagen type II matrices, and were hypothesized to partici-
pate in cartilage homeostasis [23–25], expression levels of the integrin
subunits 1, 2 and 10 were quantified to provide some initial clues on
their possible involvement in the underlying mechanisms governing these
aggregation phenomena. All target genes were normalized to housekeep-
ing gene 18S to obtain the relative gene expression. Primers used in real-
time PCR are listed in Table 1.
Table 1 The primers used for real-time PCR
Gene Oligonucleotide sequence Product
size (bp)
18S Forward 5-GTA ACC CGT TGA ACC CCA TT-3 151
Reverse 5-CCA TCC AAT CGG TAG TAG CG-3
Collagen type IIA Forward 5-GGA TGG GCA GAG GTA AAT G-3 255
Reverse 5-GGT CCT TTG GGT CCT ACA A-3
Collagen type IIB Forward 5 AGG GCC AGG ATG TCC GGC A 3 195
Reverse 5 GGG TCC CAG GTT CTC CAT CT 3
Collagen type X Forward 5 CAC TAC CCA ACA CCA AGA CA 3 225
Reverse 5 CTG GTT TCC CTA CAG CTG AT 3
Aggrecan Forward 5CAA CTA CCC GGC CAT CC 3 160
Reverse 5GAT GGC TCT GTA ATG GAA CAC 3
1 integrin Forward 5 AGG ACA GTG CCT ATA ACA CC 3 234
Reverse 5 CGC TGT CAC TTG TTG CAC TT 3
2 integrin Forward 5 ACA GAC AAG GCT GGT GAC A 3 258
Reverse 5 TGC CGT TAG CTG TAC TGT CT 3
10 integrin Forward 5 TCC GAA CGA AGG AAG AAG TG 3 193
Reverse 5 GGA AGC TCC TCT CCA TCA T 3
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Histology 
The collagen gels containing cells were fixed in 10% neutral buffered for-
malin for 10 min. at room temperature, mounted in Tissue Tek O.C.T. com-
pound, and frozen in liquid nitrogen. Sections of 7 µm were prepared,
which were stained for proteoglycans with Alcian blue-periodic acid Schiff
(AB-PAS) staining. The pH of the Alcian blue used for the staining was 2.0.
Statistical analysis
Data were obtained from five independent donors, and one gel per group
was analysed in each donor. For statistical analysis, first Levene’s test was
performed to determine the homogeneity of variance for all the data, and
then Turkey or Tamhane’s T2 post-hoc multiple comparison was performed
for the comparisons of collagen type X and aggrecan gene expression
among the five groups; a paired t-test or two-related samples nonparamet-
ric test was performed to compare integrin subunits 1,2 and 10 gene
expression among ASCs with and without co-culturing with NP 
cells. SPSS 11.0 program was employed for all statistical analysis and dif-
ferences were considered significant if P < 0.05.
Results
Distribution and cell shape of ASCs 
in collagen type II gels 
Preliminary experiments were aimed at determining the cell
distribution in different concentrations of collagen type II gels. A
homogenous distribution of ASCs was found in a range of concen-
trations of collagen type II gels (1.5–4 mg/ml gel; data not
shown). The middle concentration (2.5 mg/ml) of collagen was
used in all following experiments.
Next, Celltracker® Green labelled ASCs were encapsulated in
different densities (0.5  106, 1.5  106 and 5  106 cells/ml,
respectively) in collagen type II gels. It was observed that all cells
had already attached to the collagen type II matrix after 12 hrs,
and distributed homogenously in the matrix from top to bottom
independent of the cell seeding density. Cells had dentritic or stel-
late shapes, and connected to each other via spindle-shaped
extensions as observed under confocal imaging (Fig. 1).
Cell density-dependent contraction of collagen
type II gels
Collagen type II gels showed an ASC seeding density dependent
contraction rate from day 1 to day 14 (0.5  106 	 1.5  106 	
5  106 cells/ml, respectively) (Fig. 2). Collagen type II gels with
the highest cell density (5  106 cells/ml gel) started to contract
as early as day 1, reached their peak at day 3 and stabilized there-
after. In contrast, when cell seeding density were 1.5  106
cells/ml gel or 0.5  106 cells/ml gel, the starting time of gel con-
traction delayed to day 3 or later, and reached the lowest level only
at about day 14. When no cells were seeded, gel contraction was
negligible (Fig. 2).
NP cells direct ASCs in collagen type II gels
into a more pronounced cartilage/NP lineage 
than those in collagen type I gels
The effects of collagen type II on chondrogenic differentiation of
ASCs were investigated relative to collagen type I gels. Monolayer-
cultured ASCs served as controls.
When ASCs were cultured in monolayer, gene expression of
collagen type X and aggrecan did not significantly change 
Fig. 1 Distribution and cell shapes of ASCs seeded with different cell density in collagen type II gel. ASCs distribution was analysed after being encap-
sulated with different cell densities in collagen type II gels for 12 hrs by confocal microscopy. All the cells, independent of seeding density, had
attached to collagen type II and evenly distributed in the matrix from top to bottom with dentritic or stellate shapes. (A): 0.5  106 cells/ml gel; (B)
1.5  106 cells/ml gel; (C): 5  106 cells/ml gel. Bar: 50 µm. 
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compared to starting time point, and no induction of collagen IIA
and IIB gene expression was observed (data not shown).
Compared to monolayer controls, embedment of ASCs in collagen
type I and type II gels up-regulated gene expression of collagen
type X up to 5- and 11-fold at day 4 (although not significant),
respectively, but these values returned to monolayer levels at day 14
(Fig. 3A). No significant changes were observed in aggrecan gene
expression, irrespective of which collagen type and configuration
Fig. 2 Contraction of collagen type II gels
seeded with different cell densities of
ASCs. ASCs were encapsulated with dif-
ferent cell densities in collagen type II
gels, and the diameters of the gels were
measured from day 1 to day 14. There
was a cell density dependent gel contrac-
tion in collagen type II gels, whereas gel
contraction was not observed in the col-
lagen type II gel without seeding cells.
Fig. 3 Effects of collagen type I /II 3D environment and NP cells on collagen type X and aggrecan gene expression of ASCs. ASCs in collagen type I /II
gels were cultured alone or co-cultured with NP cells for 4 and 14 days. (A): In comparison to monolayer control, collagen type I and type II gel
embedment up-regulated the gene expression of collagen type X up to 5- and 11-fold at day 4, respectively; co-culturing with NP cells resulted in fur-
ther up-regulation of gene expression of collagen type X in ASCs in both gel types (about 28- and 20-fold higher in collagen type I and type II gel
compared to monolayer ASCs, respectively), and significant up-regulation of collagen type X gene expression by NP cells was also found by compar-
ison with ASCs cultured alone in collagen type I gels. (B): There was a highest gene expression of aggrecan in ASCs that were grown in collagen type
II gels and co-cultured with NP cells at day 14 (although not significant); T/C: treatment/control, dashed line represents monolayer control. Data are
expressed with mean ± SEM, n = 5. Abbreviations: COL I: collagen type I; COL II: collagen type II. *Comparing with monolayer control, P < 0.05.
#Comparing with ASCs cultured alone in collagen type I gels, P < 0.05.
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was used (Fig. 3B). The same was true for collagen type IIA/IIB
gene expression in ASCs (data not shown). 
To study the potential contribution of NP cells in the differ-
entiation process of ASCs cultured in either collagen type I or
type II gels, transwell co-cultures with micromass NP cells were
performed, and at day 4 and day 14 ASCs were harvested and
analysed for expression of NP-phenotype related markers. It
was found that at day 4 the presence of NP cells resulted in fur-
ther enhancement of collagen type X gene expression in ASCs
in both gel types (about 28- and 20-fold higher in collagen type
I and type II gel compared to monolayer ASCs, respectively).
Up-regulation of collagen type X gene expression by NP cells
was also found to be significant when compared to ASCs
cultured in collagen type I gels (Fig. 3A). Aggrecan gene expres-
sion was highest when ASCs were grown in collagen type II gels
and co-cultured with NP cells, although there were no signifi-
cant differences found among these five groups (Fig. 4B). Most
striking differences were observed in the gene expression pro-
files of collagen type II: Collagen type IIA (early chondrogenic
marker) was only induced in collagen type I-embedded ASCs
from two out of five donors at day 4, and not at other time
points. In contrast, both collagen type IIA and IIB (late chondro-
genic marker) were induced in ASCs in collagen type II gels at
day 4 or/and day 14, with a shift from collagen type IIA to
collagen type IIB in three of five donors between day 4 and day
14 (Table 2). 
Alcian blue staining demonstrated enhancement of proteogly-
can staining intensity by NP cells in both collagen type I and 
Fig. 4 Effect of collagen type I/ II 3D environment and NP cells on alcian blue staining of ASCs. ASCs were cultured in collagen type I or type II gels
alone, or indirectly co-cultured with NP cells for 4, 14 and 21 days. NP cells could greatly enhance the alcian blue staining of ASCs in either collagen
type I and type II gels; collagen type II gels displayed stronger staining than collagen type I gels independent of whether ASCs were cultured alone or
co-cultured with NP cells. Abbreviations: COL I: collagen type I; COL II: collagen type II. Bar: 250 µm.
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type II ASC-loaded matrices. Collagen type II gels displayed
stronger staining than collagen type I gels in both situations
(absence and presence of NP cells) (Fig. 4). 
NP cells modulate ASCs distribution pattern 
in collagen type II gels
During our cultures, striking differences could be observed in the
aggregation behaviour between the various experimental groups.
Starting from around day 7 of culturing, strong cellular condensa-
tion/ aggregation and ‘island formation’ was observed when ASCs
were embedded in collagen type II (Fig. 5, upper panel), but not
when embedded in collagen type I (data not shown). However, to
our surprise, collagen type II- embedded ASCs in the presence of
NP cells did show a severe delay or even prevention of these aggre-
gation phenomena (Fig. 5, lower panel). The absence of aggrega-
tion events in collagen type I gels was not influenced by NP cells
(data not shown). 
NP cells down-regulate integrin subunit 2 gene
expression of ASCs in collagen type II gels 
To gain insight on why NP cells modulated the striking ASCs dis-
tribution pattern in collagen type II gels, gene expression profiles
of collagen type II receptor-integrin subunits 1, 2 and 10 were
determined in both collagen type II-embedded ASC groups (1/–
NP cells). It was found that co-culture with NP cells significantly
down-regulated gene expression of integrin subunit 2, but not
the integrin subunits 1, 10 at day 4 (Fig. 6B). At day 14, although
the trend was still pronounced, no significant changes for either
integrin subunit was observed any more (Fig. 6A–C).
Discussion
Tissue microenvironments play a crucial role in normal regenera-
tive processes. MSCs, as a part of normal regenerative processes,
are believed to migrate and circulate away from their niches [26],
and can differentiate into various anchorage-dependent cells types,
such as osteoblasts [27, 28], neurons [29] and NP cell-like cells
[30] in vivo. It is crucial to know how the individual components
of the tissue microenvironment interact with each other to guide
this anchorage-dependent cell differentiation. 
In a previous study, we showed that micromass NP cells can
successfully induce the NP phenotype in micromass ASCs (but
not in monolayer ASCs) through soluble bio-factors in an indirect
co-culture system [22]. This result is consistent with two other
published reports in which chondrogenic differentiation was
induced in embryonic stem cells or rabbit ASCs by soluble factors
produced by primary chondrocytes or NP cells in indirect co-
culture systems [31, 32]. The indirect co-culture setup was select-
ed because our driving hypothesis was (and is) that, due to the
high matrix-to-cell ratio in the NP, most of the ASCs will experi-
ence only indirect contact with NP cells via soluble factors.
However, this at the same time implies that the microenvironment
the ASCs will encounter after intradiscal injection will predomi-
nantly be a 3D matrix containing collagen type II. In the current
study, we aimed to closely mimic this in vivo situation by seeding
ASCs in 3D collagen type II gels and indirect co-culturing with NP
cells. Our current data show: (i) A 3D environment per se (i.e. both
collagen type I and type II gels) results in significant up-regulation
of the gene expression of collagen type X but not of other markers
associated with chondrogenesis (Fig. 3); (ii) Embedding of ASCs
in collagen type II, but not in collagen type I gels, in the presence
of NP cells provokes a more pronounced ASC differentiation
towards the NP phenotype.
In general, a 3D environment, such as in collagen, fibrin and
alginate gels, is required for chondrocytes to maintain their differ-
entiated chondrogenic phenotype or for MSCs to undergo chon-
drogenic differentiation in vitro [33–36]. An important finding of
the current study is that apparently an additional level of control of
the chondrogenic response of ASCs may be achieved by optimiz-
ing the composition of the matrix environment they will encounter.
Interestingly in this regard is that even though the effects of the
matrix in itself appeared minor (only a modest difference in up-
regulation (twofold) when comparing the collagen type X gene
expression of collagen type I versus type II gels in favour of the
latter, and no expression differences for the other chondrogenesis-
associated markers), the matrix type appeared to ‘potentiate’ the ASCs
Table 2 Induction of collagen type IIA and IIB gene expression of
ASCs embedded in collagen type I or type II gels and co-cultured with
NP cells
Collagen
gel type
Donor
Day 4 Day 14
Col IIA Col IIB Col IIA Col IIB
I
1 – – – –
2 + – – –
3 + – – –
4 – – – –
5 – – – –
II
1 – – + –
2 + + – +
3 + – – +
4 + – – +
5 – – + +
Note: –: undetectable in 45 PCR cycles; +: detectable in 45 PCR cycles.
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Fig. 5 Effect of NP cells on ASCs distribution pattern in collagen type II gel. ASCs in collagen type II gels were either cultured alone or co-cultured with
NP cells over 14 days. When ASCs in collagen type II gels were cultured without NP cells (upper panel), ASCs began to aggregate around day 7 and
formed striking 'islands' around day 14. This ASC aggregation was prevented/delayed by NP cells (lower panel). COL II: collagen type II. Bar: 150 µm.
Fig. 6 Effects of NP cells on integrin subunits 1, 2 and 10 gene
expression of ASCs in collagen type II gels. ASCs in collagen type II
gels were cultured alone or co-cultured with NP cells for 4 and 14 days.
By comparing these two groups, (A): There was no significant differ-
ence of integrin subunit 1 gene expression at day 4 and day 14
between these two groups; (B): NP cells significantly down-regulated
the gene expression of integrin subunit 2 in ASCs at day 4; (C): There
was no significant difference of gene expression of integrin subunit 10
between these two groups. Abbreviations: COL II: collagen type II, ITG:
integrin. Data are expressed with mean ± SEM, n = 5. *P < 0.05.
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for a stronger response to chondrogenic influences of the NP cells in
our co-culture studies.
The early up-regulation of collagen type X expression as
observed in this study does not match with the traditional view
that this collagen should be regarded as a late marker, associated
with hypertrophic, mineralizing chondrocytes [37]. In contrast,
our data suggest that collagen type X induction is an early event,
probably at least partly induced by placement of ASCs in a 3D
environment, but less dependent of the collagen type the cells
‘feel’. Also, the response to chondrogenic induction media
appears to be relatively independent of the matrix type (Fig. 3A).
Interestingly, and in accordance with our own findings, the early
up-regulation of collagen type X has recently been recognized by
other research groups as well [38, 39]. Although merely specula-
tive, this might suggest a hitherto unrecognized role for collagen
type X in early chondrogenic differentiation, or even a response to
a changed environment (see above; from 2D-cultured to 3D-hydro-
gel embedded cells) per se that may be not or only indirectly be
linked to chondrogenic events. 
After ASCs were co-cultured with NP cells, we observed that
ASCs in collagen type II gel displayed a more pronounced chon-
drogenic phenotype than ASCs in collagen type I gels: stronger
alcian blue staining and induction of both collagen type IIA and
IIB gene expression (Table 2, Fig. 4). It has been shown that col-
lagen type IIA transcripts are synthesized by prechondrocytes
whereas collagen type IIB transcripts are synthesized by mature
chondrocytes [39, 40]. That collagen type II is more able to main-
tain or induce a chondrogenic phenotype has also been shown in
several other studies [41–43]. To the best of our knowledge,
mechanisms behind the property of collagen type II (maintenance
or induction of chondrogenic phenotype) are still remaining
unclear. Herein we only can speculate that collagen type I and col-
lagen type II have different preferences to bind or induce different
members of the integrin 1 family, and thereby follow a different
signal pathway leading to chondrogenesis, because integrin 
1 family plays a crucial role in chondrogenesis [44] and has a
cross-talk with growth factors such as transforming growth 
factor-1(TGF-1) [45].
In this study, ASCs attached to collagen type II matrix as evi-
denced by different cell densities of ASCs homogenously distrib-
uted in the different concentrations (from 1.5 to 4 mg/ml) of col-
lagen type II matrix with the stellate shapes (Fig. 1, data not shown
for the low and high concentrations of collagen type II gel) within
12 hrs. There was also a cell density-dependent gel contraction in
collagen type II gels embedded with ASCs (Fig. 2). Integrins com-
prise a group of receptors on the cell surface that mediate
cell–ECM interactions. All receptors consist of one  and one 
subunit which together form a non-covalently bound heterodimer
[46]. The integrins 11, 21 and 101 have been identified to
interact with collagen type II, and each of them separately or in
combination might be involved in the attachment of ASCs.
Because these integrins have distinct signalling functions due to
their different short intracellular domains of the collagen-binding
 units [23, 47, 48], we determined the expression patterns of all
 subunits in an effort to assess which integrin might be primari-
ly involved in the aggregation events observed in collagen type II
gels, and its delay after co-incubation with NP cells (Fig. 5).
Although far from conclusive, the significant down-regulation of
integrin subunit 2 gene expression in the collagen type II/NP cell
combination (Fig. 6B) suggests that the change in ASC aggrega-
tion rate imposed by the NP cells may be mediated by NP cell-
secreted factors affecting the expression level of the integrin 21.
Further studies are warranted to substantiate the potential role of
this particular integrin in ASC condensation events, as well as the
nature of the soluble factor(s) involved.
In conclusion, collagen type II can provide an appropriate
scaffold for the attachment of ASCs. In addition, it was found
that a microenvironment consisting of collagen type II hydro-
gels in combination with soluble factor-secreting NP cells, can
direct ASC differentiation more efficiently towards a more
advanced cartilage/NP lineage than ASCs in a collagen type I/NP
cell combination. Furthermore, the different collagen type II
receptors-integrin 11, 21 and 101 in ASCs may exert 
different functions in response to collagen type II, where inte-
grin 21 is more likely involved in mediating ASC aggregation.
The findings from this study allow us to proceed to in vivo
experiments in which ASCs will be used for the injection treat-
ment for mildly DDD.
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